GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Merit Medical Systems Inc (NAS:MMSI) » Definitions » Cash Conversion Cycle

MMSI (Merit Medical Systems) Cash Conversion Cycle : 172.42 (As of Mar. 2025)


View and export this data going back to 1992. Start your Free Trial

What is Merit Medical Systems Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Merit Medical Systems's Days Sales Outstanding for the three months ended in Mar. 2025 was 50.05.
Merit Medical Systems's Days Inventory for the three months ended in Mar. 2025 was 155.29.
Merit Medical Systems's Days Payable for the three months ended in Mar. 2025 was 32.92.
Therefore, Merit Medical Systems's Cash Conversion Cycle (CCC) for the three months ended in Mar. 2025 was 172.42.


Merit Medical Systems Cash Conversion Cycle Historical Data

The historical data trend for Merit Medical Systems's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merit Medical Systems Cash Conversion Cycle Chart

Merit Medical Systems Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 160.72 148.14 155.33 167.71 171.21

Merit Medical Systems Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 181.31 177.19 173.19 170.86 172.42

Competitive Comparison of Merit Medical Systems's Cash Conversion Cycle

For the Medical Instruments & Supplies subindustry, Merit Medical Systems's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merit Medical Systems's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Merit Medical Systems's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Merit Medical Systems's Cash Conversion Cycle falls into.


;
;

Merit Medical Systems Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Merit Medical Systems's Cash Conversion Cycle for the fiscal year that ended in Dec. 2024 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=49.53+156.08-34.4
=171.21

Merit Medical Systems's Cash Conversion Cycle for the quarter that ended in Mar. 2025 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=50.05+155.29-32.92
=172.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merit Medical Systems  (NAS:MMSI) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Merit Medical Systems Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Merit Medical Systems's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Merit Medical Systems Business Description

Traded in Other Exchanges
Address
1600 West Merit Parkway, South Jordan, UT, USA, 84095
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
Executives
Neil Peterson officer: Chief Operating Officer 1600 MERIT PARKWAY, SOUTH JORDAN UT 84095
Fred P Lampropoulos director, officer: President & CEO
Brian G. Lloyd officer: Chief Legal Officer, Secretary 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Raul Jr. Parra officer: Interim CFO 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Stephen C. Evans director C/O ALARM.COM HOLDINGS, INC., 8281 GREENSBORO DRIVE, SUITE 100, TYSONS VA 22102
Michel James Voigt officer: Chief Human Resources Officer 1600 W MERIT PARKWAY, SOUTH JORDAN UT 84095
F. Ann Millner director 4275 SPRING ROAD, OGDEN UT 84403
Joseph Wright officer: President, International 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Thomas James Gunderson director 5905 LONG BRAKE TRAIL, EDINA MN 55439
A Scott Anderson director ONE SOUTH MAIN, SUITE 1134, SALT LAKE CITY UT 84111
Lynne Ward director 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Ronald Frost officer: Chief Operating Officer 1600 WEST MERIT PARKWAY, SOUTH JORDAN X1 84095
Robert Fredericks officer: Chief Strategy & Innovation O. 1600 MERIT PARKWAY, SOUTH JORDAN UT 84095
Michael R Mcdonnell director C/O IQVIA HOLDINGS INC., 83 WOOSTER HEIGHTS ROAD, DANBURY CT 06810
Laura S. Kaiser director 10101 WOODFIELD LANE, ST. LOUIS MO 63132